Presentation of the company and the development of linaprazan glurate from Redeye Transactions

Here you can watch the full presentation of Cinclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at Redeye Transactions June 13th.
Cinclus Pharma: CEO Christer Ahlberg presents at Redeye Transactions – 13th June 2024